Newstral
Article
Star Telegram on 2024-05-06 14:30
Crofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for Chemotherapy-Induced Diarrhea in Dogs, is the Subject of the Company’s Investigational New Animal Drug Application for the Indication of General Diarrhea in Dogs
Related news
- Diarrhea spike has city on the runsCNN
- AVCU researchers begin clinical trials on investigational drug therapy for COVID-19augustafreepress.com
- Déjà Vu All Over Again: OPDP Sends Another Letter Regarding Website Promotion of an Investigational New Drugjdsupra.com
- Mexico’s rescue and drug-sniffing dogs start out at the army’s puppy kindergartenSeattle Times
- The EMA opens a draft guideline for handling and shipping of investigational medicinal products for human use for public consultation.jdsupra.com
- MBiohaven's investigational anxiety drug fails in trialmarketwatch.com
- Norovirus is spreading throughout the U.S., causing vomiting, diarrhea in unlucky patientsStar Telegram
- Ask the Vet: Diarrhea is a common — and frustrating — problem in dogsThe Toledo Blade
- Sniffer dogs, drug testing under reviewtheage.com.au
- Diarrhea Planet @The Jinxconnectsavannah.com
- MDog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health’s Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)miamiherald.com
- Going to the Dogsthecantoncitizen.com
- Running of the Dogsbendsource.com
- D.N.J. Dumps Diarrhea Drug Case Against Manufacturerjdsupra.com
- Making the Dogs of ‘Isle of Dogs’The New York Times
- FDA conditionally approves controversial Alzheimer’s drugThe Hindu
- TJogging With the DogsThe Folsom Telegraph
- MVaccinex's stock falls after investigational drug fails Huntington's disease studymarketwatch.com
- Airport going to the dogsThe Crescent-News
- Cats and dogs owner who harassed neighbours conditionally dischargedtimesofmalta.com